5AM Partners VII, LLC
SEC Form 4 insider trading activity
5AM Partners VII, LLC has filed 3 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.
On the most recent filing, 5AM Partners VII, LLC is listed as 10% Owner at Skye Bioscience, Inc. Inside the rolling window, 5AM Partners VII, LLC reported no open-market purchases and 6 open-market sales totaling $445K in SKYE. The largest disclosed transaction in the window is a sale of 119,379 SKYE shares on Sep 23, 2026, worth $192K.
Companies traded
Other insiders at SKYE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$445K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has 5AM Partners VII, LLC made?
5AM Partners VII, LLC has filed 3 SEC Form 4 filings (15 transaction rows) across 1 company since 2026.
Which companies does 5AM Partners VII, LLC trade?
5AM Partners VII, LLC has filed SEC Form 4 disclosures for 1 company, including SKYE.
When was 5AM Partners VII, LLC's most recent SEC Form 4 filing?
5AM Partners VII, LLC's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.
What is 5AM Partners VII, LLC's total buy and sell value in the current window?
Inside the rolling retention window, 5AM Partners VII, LLC bought $0 and sold $445K based on SEC Form 4 filings.
What was 5AM Partners VII, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 119,379 SKYE shares on 2026-09-23, worth $192K, per SEC Form 4 filings.